Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.47 CAD | +2.17% | +17.50% | +9.30% |
Mar. 27 | Satellos Bioscience Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Mar. 27 | Satellos Bioscience Announces FY 2023 Results | MT |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 38.8M 53.04M |
---|---|---|---|---|---|
Net income 2024 * | -15M -20.5M | Net income 2025 * | -11M -15.04M | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-2.47
x | P/E ratio 2025 * |
-2.35
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 87.55% |
1 day | +2.17% | ||
1 week | +17.50% | ||
Current month | +4.44% | ||
3 months | -11.32% | ||
6 months | +51.61% | ||
Current year | +9.30% |
Managers | Title | Age | Since |
---|---|---|---|
Frank Gleeson
FOU | Founder | 68 | 17-12-31 |
Michael Rudnicki
FOU | Founder | - | 17-12-31 |
Director of Finance/CFO | - | 23-08-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Franklin Berger
BRD | Director/Board Member | 74 | - |
Geoff MacKay
CHM | Chairman | 57 | 18-08-31 |
William McVicar
BRD | Director/Board Member | 66 | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 0.47 | +2.17% | 39,000 |
24-05-09 | 0.46 | +2.22% | 21,000 |
24-05-08 | 0.45 | +2.27% | 28,650 |
24-05-07 | 0.44 | +2.33% | 42,500 |
24-05-06 | 0.43 | +7.50% | 39,001 |
Delayed Quote Toronto S.E., May 10, 2024 at 03:17 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+9.30% | 38.8M | |
+3.91% | 109B | |
+10.87% | 105B | |
+1.28% | 22.25B | |
-13.14% | 22.09B | |
-7.05% | 18.68B | |
-38.36% | 17.58B | |
-10.66% | 16.85B | |
+3.75% | 13.76B | |
+36.70% | 12.46B |
- Stock Market
- Equities
- MSCL Stock